Active B6 for hormone and neurotransmitter support. The coenzyme form of B6. It's the cofactor behind serotonin, dopamine and GABA formation, amino acid handling and the first step of haem synthesis.
Reviewed March 2026
Public health figures for this ingredient, reported by the agencies that publish them, cited and dated.
About 31% of US women aged 71 and over
take in less vitamin B6 from food and drink than the estimated average requirement.
USDA ARS, Usual Nutrient Intake from Food and Beverages, by Gender and Age, WWEIA NHANES 2013-2016, Table A 21 (vitamin B6), females 71+: 31% below EAR (SE 3.1). ↗About 24% of US women aged 51 to 70
take in less vitamin B6 from food and drink than the estimated average requirement.
USDA ARS, Usual Nutrient Intake from Food and Beverages, by Gender and Age, WWEIA NHANES 2013-2016, Table A 21 (vitamin B6), females 51-70: 24% below EAR (SE 1.9). ↗About 17% of US women aged 19 and over
take in less vitamin B6 from food and drink than the estimated average requirement.
USDA ARS, Usual Nutrient Intake from Food and Beverages, by Gender and Age, WWEIA NHANES 2013-2016, Table A 21 (vitamin B6), females 19+: 17% below EAR (SE 1.3). ↗About 15% of US men aged 71 and over
take in less vitamin B6 from food and drink than the estimated average requirement.
USDA ARS, Usual Nutrient Intake from Food and Beverages, by Gender and Age, WWEIA NHANES 2013-2016, Table A 21 (vitamin B6), males 71+: 15% below EAR (SE 1.6). ↗Population figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.
Source: NIH ODS + Dalton 1987 neuropathy study
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
P5P (High Dose B6) has emerging evidence. Based on 17+ studies.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Pyridoxal kinase and most PLP-dependent transaminases run with magnesium as the required metal ion. The two are combined across formulation practice for that reason.
Pyridoxine 5-phosphate oxidase is FMN-dependent, so riboflavin is what converts pyridoxine into pyridoxal-5-phosphate. Even with P5P supplied directly, riboflavin governs recycling within the same pool.
Pyridoxal kinase, which phosphorylates B6 into its coenzyme form, is zinc-dependent. Zinc therefore serves the activation and recycling of the vitamin.
B12 and folate remethylate homocysteine to methionine while P5P carries it down the transsulfuration branch to cysteine. Covering both routes keeps the pathway from backing up at either exit.
Serine hydroxymethyltransferase, which loads one-carbon units onto folate, is a PLP enzyme. B6 and folate are physically linked at that step, not merely co-formulated.
Betaine sends homocysteine back to methionine through BHMT while P5P routes it forward to cysteine. The two cover opposite exits from the same intermediate.
Aromatic amino acid decarboxylase and kynureninase both require pyridoxal-5-phosphate, so tryptophan cannot move along either of its main routes without B6. P5P is the enabling cofactor for the conversion.
Aromatic L-amino acid decarboxylase converts 5-HTP to serotonin using pyridoxal-5-phosphate as its cofactor. Without B6 the conversion step is the bottleneck.
The same PLP-dependent decarboxylase converts L-DOPA derived from tyrosine into dopamine. B6 sits at the decarboxylation step of catecholamine synthesis.
Glutamate decarboxylase, the enzyme that forms GABA from glutamate, requires pyridoxal-5-phosphate. B6 governs endogenous production of the same molecule.
Cysteine sulfinate decarboxylase, the rate-limiting step from cysteine to taurine, is PLP-dependent. B6 status sets how much taurine is made from sulfur amino acids.
Delta-aminolevulinate synthase, the first and rate-limiting enzyme of haem synthesis, requires pyridoxal-5-phosphate. Iron supplies the metal and B6 the ring-building step in normal red cell formation.
Both enzymes of transsulfuration, cystathionine beta-synthase and cystathionine gamma-lyase, are pyridoxal-5-phosphate enzymes. Without the coenzyme, homocysteine cannot be converted through cystathionine into cysteine. The relationship is a settled cofactor dependency rather than a trial result.
Serine hydroxymethyltransferase is PLP-dependent and moves a one-carbon unit from serine onto tetrahydrofolate, generating glycine in the process. Serine is also the condensation partner for homocysteine in cystathionine synthesis, another PLP step. Serine metabolism and B6 status are hard to separate.
The glycine cleavage system carries a PLP-dependent component, and the serine to glycine interconversion runs on a PLP enzyme. Glycine turnover therefore tracks B6 status. This is standard one-carbon biochemistry.
Methionine loading raises homocysteine, and the PLP-dependent transsulfuration branch is one of the two routes that clears it. Adequate coenzyme keeps that branch open. Homocysteine is a metabolic marker here, not an outcome.
Histidine decarboxylase is a PLP enzyme, and histidine catabolism through formiminoglutamate also intersects folate handling. Coenzyme availability sets the pace of both steps. The dependency is textbook enzymology.
Ornithine aminotransferase, which links arginine and ornithine to glutamate semialdehyde, is PLP-dependent, so arginine handling touches B6 status. A 2025 report in Current Developments in Nutrition describes pyridoxine given alongside arginine supplementation under a lysine-restricted diet in a defined clinical group. That is a specialist protocol under supervision, not a general-purpose pairing.
Ornithine aminotransferase requires pyridoxal-5-phosphate to transaminate ornithine. The step connects the urea cycle to glutamate and proline metabolism. It is a settled cofactor relationship.
Aromatic L-amino acid decarboxylase, the PLP enzyme that turns L-DOPA into dopamine, sits downstream of phenylalanine and tyrosine hydroxylation. Supplying the aromatic amino acid without the coenzyme leaves the decarboxylation step limited. The pairing is pathway logic, not a measured mood or performance outcome.
Melatonin is made from serotonin, and serotonin comes from 5-hydroxytryptophan by way of the PLP-dependent aromatic amino acid decarboxylase. B6 sits upstream of the whole branch. Taking melatonin itself bypasses that chemistry, so the two overlap only at the endogenous end.
Kynureninase, the enzyme that converts 3-hydroxykynurenine toward the niacin precursor quinolinate, is PLP-dependent. Low coenzyme status shunts tryptophan toward xanthurenic acid instead, which is the basis of the classic tryptophan load test. This is a documented pathway relationship, and urinary metabolites are markers rather than outcomes.
Transsulfuration hands sulfur to cysteine, and sulfite oxidase, a molybdenum enzyme, completes the disposal of sulfur as sulfate. B6 opens the upstream branch and molybdenum closes the downstream one. The two cover different ends of a single sulfur route.
S-adenosylmethionine allosterically activates cystathionine beta-synthase, the first PLP-dependent transsulfuration enzyme. Coenzyme availability and allosteric activation are separate controls on the same step. Neither substitutes for the other.
Choline is oxidised to betaine, which remethylates homocysteine back to methionine and therefore competes with the PLP-dependent route that sends homocysteine to cysteine. The balance between the two branches shifts with the supply of each nutrient. Homocysteine is the shared marker.
Aminotransferases that move nitrogen between glutamate, alanine and aspartate all carry pyridoxal-5-phosphate at the active site. Glutamine feeds that nitrogen pool through glutaminase. Amino acid nitrogen traffic runs on B6.
Dopamine beta-hydroxylase is a copper enzyme that acts on dopamine, which is itself produced by a PLP-dependent decarboxylation. The two micronutrients sit in sequence on the catecholamine route. This is mechanistic sequencing rather than a combination trial.
Ascorbate is the reducing cofactor for dopamine beta-hydroxylase, one step past the PLP-dependent decarboxylation in catecholamine synthesis. Each nutrient serves a different enzyme on the same short chain. The connection is pathway-level.
Nothing specific on file for P5P (High Dose B6). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.Pyridoxal-5-phosphate is the coenzyme-active form of vitamin B6. Pyridoxine, pyridoxal and pyridoxamine are converted to it by pyridoxal kinase followed by pyridoxine-5-phosphate oxidase, which is an FMN enzyme and therefore riboflavin-dependent.
Pyridoxal-5-phosphate forms a Schiff base with a lysine residue at the enzyme active site and then with the incoming amino acid, which is the chemistry behind more than one hundred and forty catalogued PLP-dependent reactions.
Transaminases including alanine aminotransferase and aspartate aminotransferase are PLP enzymes, which is why amino acid nitrogen transfer depends on vitamin B6 status.
Aromatic L-amino acid decarboxylase converts 5-hydroxytryptophan to serotonin and L-DOPA to dopamine, and glutamate decarboxylase converts glutamate to GABA. Both are PLP-dependent decarboxylations.
There is no plant or animal source for this one. It is built in a chemical plant, first as ordinary pyridoxine, then converted with two more reactions into the active coenzyme form, crystallised, dried away from light and tested before it goes into a capsule.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
Industrial vitamin B6 synthesis starts from simple commodity chemicals rather than from a plant or animal source. Common routes build the pyridine ring by a Diels-Alder cycloaddition between a substituted oxazole and a dienophile.
The cycloaddition adduct is aromatised and functionalised to give pyridoxine, which is isolated as the hydrochloride salt. This is the same intermediate used for ordinary pyridoxine HCl products.
Pyridoxine is oxidised at the 4-position to the aldehyde and phosphorylated at the 5-hydroxymethyl position, giving pyridoxal-5-phosphate. Order and reagents vary by manufacturer, and some routes phosphorylate first.
The product is crystallised from water under controlled pH and dried, yielding the yellow monohydrate. Light is excluded from this point onward because the aldehyde vitamer is photolabile.
Batches are assayed for pyridoxal-5-phosphate content, related vitamers, residual solvents and heavy metals, and are packed in light-resistant containers.
The dried crystals are milled and blended with carriers and flow aids, often in an opaque capsule or a coated tablet to limit light exposure on the shelf.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
These are the studies our verdict leans on, chosen from the 8 we read for P5P (High Dose B6). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.